Poly(L-Lactide) CAS 33135-50-1 - China Factory, Suppliers, Manufacturers

Poly(L-Lactide) CAS 33135-50-1, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Poly(L-Lactide) ; PLLA CAS 33135-50-1 Purity ≥98.0% High Purity — Poly(L-Lactide) PLLA CAS 33135-50-1 Medical Grade Factory High Quality
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...

2022.12.11 14:04:53
2022.11.05 10:59:29
2022.08.26 17:58:03
2022.07.08 13:38:21
2022.02.27 20:52:32
2022.01.29 22:25:29

Poly(L-Lactide) CAS 33135-50-1 - China Factory, Suppliers, Manufacturers

Related Products

Poly(L-Lactide) PLLA CAS 33135-50-1 Medical Grade Factory High Quality

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

3-(Trifluoromethyl)pyrazole CAS 20154-03-4 Purity >99.0% (GC) Factory

Formamidine Acetate CAS 3473-63-0 Purity >99.0% (HPLC) Factory Hot Selling

3-Fluoro-D-Phenylalanine CAS 110117-84-5 H-D-Phe(3-F)-OH Purity >99.0% (HPLC)

4'-Ethoxyacetophenone CAS 1676-63-7 Purity >99.0% (GC)

m-Tolualdehyde 3-Methylbenzaldehyde CAS 620-23-5 Factory High Quality

Sitagliptin CAS 486460-32-6 Purity >99.0% (HPLC) API Factory High Purity

Z-Lys(Boc)-OH·DCHA CAS 2212-76-2 Purity >98.5% (HPLC) Factory

Boc-Asp-OtBu CAS 34582-32-6 Purity >99.0% (HPLC) Factory

2,4-Dichloro-6-Methoxy-1,3,5-Triazine CAS 3638-04-8 Purity >97.0%

4-Androsten-3-One-5-Ene-17-Carboxylic Acid CAS 302-97-6 Purity >99.0% (HPLC) Finasteride Intermediate Factory

2-Picoline N-Oxide CAS 931-19-1 Purity >99.0% (GC) Factory

1,3-Bis(2,6-diisopropylphenyl)imidazolium Chloride CAS 250285-32-6 Purity >98.0% (HPLC) Factory

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

Method Of Analyzing Palladium Content In Palladium Catalysts

New COVID treatments offer hope

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The “Summit on COVID-19 Diagnostics & Treatment”

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

2022.12.11 14:04:53

2022.11.05 10:59:29

2022.08.26 17:58:03

2022.07.08 13:38:21

2022.02.27 20:52:32

2022.01.29 22:25:29

related search